Thyroid Diagnosis

Disorders of the thyroid gland are the most common problems encountered by people in the young and middle adulthood. Women have a higher incidence rate for thyroid disorders. The problems experienced by people with thyroid gland disorders can be really life-threatening so early and appropriate interventions should be given. The appropriate diagnostic tests are essential for proper diagnosis of the disease.

Diagnostic Tests for your Thyroid Gland Blood Test: The test needed to determine if your thyroid has any deviations or performing normally is through blood test. The Serum T3 or triiodothyroxine as well as T4 or thyroxine is the indicators for any disorders of the thyroid. If the T3 and T4 level are low, then a person may be diagnosed of hypothyroidism. On the other hand, if the thyroxine levels are high, then a person may be experiencing hyperthyroidism or Grave’s disease. To determine if thyroid cancer is a concern, the thyroglobulin for follicular adenocarcinoma can become markers for the disease.

Ultrasound: Another diagnostic test is the ultrasound. It is used to determine the structure and consistency of the thyroid gland. They are essential to determine if the nodules of the thyroid are benign or malignant. The ultrasonic waves of the machine produce a highly defined picture of the thyroid gland. To consider a thyroid gland as benign, it should have smooth borders and hyperechoic (more echogenic than the surrounding tissues). On the other hand, a nodule is malignant if it has irregular borders, hypoechoic (less echogenic than the surrounding tissues), microcalcifications or the formation of calcium deposits in the nodules and significant intranodular blood flow. But ultrasound is not considered as a reliable source to determine the existence of cancer. It can be used for the determination of the enlargement of the thyroid.

Radioactive Scanning: A more accurate means to determine disorders of the thyroid is the radioactive scanning and uptake. The radioactive scanning is performed with the use of a radioactive iodine medium. This radioactive medium collects or stays in the thyroid gland before it is excreted in the urine. With the use of the radioactive scanning, you can determine the shape and the activity of your thyroid gland. An abnormality in the gland may be seen through the irregularity of the uptake as well as the location of the gland. For instance, if a portion of the gland is overactive causing to inhibit the actions of the rest of the glands, this could be diagnosed as an adenoma. This disorder can easily be prevented through surgery. On the other hand, if the gland is under active. This may be diagnosed as thyroid cancer because a part of the gland ceases to function normally. The radioactivity exhibited by the gland will determine or serve as an indicator of the metabolic capacity of the gland. The radioactive uptake demonstrates 8 to 35 percent of the gland’s activity. It can determine with 24 hours after administration of radioiodine. If the uptake is low, it can predispose to hypothyroidism. If it is high, this can be diagnosed as hyperthyroidism.

For those who have are at risk of having thyroid cancers, you can submit to biopsy to determine if the nodules of your thyroid gland are benign or malignant.

These are the diagnostic test you can use to determine if your thyroid gland is in its optimal condition or not. “Prevention is better than cure!” so you should take good care of your body. Eat the right kind and amount of foods daily, perform exercises and control all your stresses in life. These things may contribute to a healthier living and may prevent any foreseeable crises that may arise.

Abstract
Introduction  Lymphadenectomy and thyroidectomy is standard treatment for medullary thyroid carcinoma (MTC), but the prognostic importance
of the number of lymph nodes removed (lymph node yield, LNY) and the proportion of metastatic lymph nodes resected (metastatic
lymph node ratio, MLNR) is unknown. We hypothesized that MTC survival is influenced by LNY and MLNR.

Methods  Patients (N = 534) who underwent thyroidectomy with lymphadenectomy for MTC between 1988 and 2004 were identified in the Surveillance,

Abstract
Background  Papillary carcinoma with clinically apparent node metastasis but lacking a primary carcinoma lesion in the thyroid is designated
as occult papillary carcinoma. In the era of routine ultrasonographic examination, occult papillary carcinoma is defined as
papillary carcinoma with clinically apparent node metastasis but showing a primary lesion that is microscopic or overlooked
by ultrasonography. In this study we investigated the prevalence and clinicopathologic features, including prognosis, of occult
papillary carcinoma.

Abstract  Patients undergoing malabsorptive weight-loss procedures are at increased risk of calcium and vitamin D deficiency. Thyroidectomy
carries the risk of both immediate and long-term hypocalcemia. Here we describe a patient who underwent Roux-en-Y gastric
bypass (RYGB) and subsequent near-total thyroidectomy and then developed refractory hypocalcemia. Serum calcium reached a

Abstract
Background  Chyle leakage is an uncommon complication of lateral neck dissection for metastatic papillary thyroid carcinoma (PTC). There
have been no reports on chyle leakage after central neck dissection not combined with lateral neck dissection. We therefore
investigated chyle leakage in PTC patients undergoing thyroidectomy and central neck dissection.

Methods  A total of 283 new patients with differentiated PTC underwent total thyroidectomy plus central neck dissection. The amount

Abstract
Background and aims  The role of central neck dissection in the treatment of papillary thyroid carcinoma is debated. This retrospective investigation
was undertaken to assess whether it augments total thyroidectomy morbidity.

Patients/methods  A total of 305 consecutive patients who had undergone total thyroidectomy for papillary thyroid carcinoma were divided into

Thyroidectomies from patients with history of therapeutic radiation during childhood and adolescence have a unique mutational profile

Modern Pathology advance online publication, June 27, 2008. doi:10.1038/modpathol.2008.122

Authors: Adel Assaad, Laura Voeghtly
& Jennifer L Hunt (Source: Modern Pathology AOP)  MedWorm Sponsored Message: Find out how you can get your message across here by sponsoring this MedWorm news feed.

Abstract
Background  In surgery for primary hyperparathyroidism, preoperative localization together with intraoperative parathyroid hormone assay
is important when minimal invasive operations of the parathyroid glands are intended. In cases of reoperation, correct localization
of the abnormal parathyroid glands is extremely instrumental. Computed tomography (CT)–99mTc-sestamibi (MIBI)–single photon emission computed tomography (SPECT) image fusion allows for a virtual exploration of the

Related Articles
Patterns of relapse following radiotherapy for differentiated thyroid cancer: Implication for target volume delineation.

Page: 231DOI: 10.1097/SLE.0b013e31816907d0Authors: Bae, Ja Seong MD *; Cho, Young Up MD +; Sung, Gi Young MD *; Oh, Se Jeong MD *; Jung, Eun Jung MD ++; Lee, Jae Bok MD [S]; Kim, Tae Hyun MD [//]; Nam, Kee-Hyun MD [P]; Chung, Woong Youn MD [P]; Yoon, Jung Han MD [sharp]; Kim, Lee Su MD **; Park, Yong Lai MD ++; Kim, Jung Han MD ++; Moon, Byung In MD ++++; Lee, Jong Riul MD [S][S]; Lee, Byoung Un MD [//][//]; Kim, Jee-Soo MD [P][P]; Yoon, Jong Ho MD **; Kim, Je Ryong MD [sharp][sharp]; Soh, Euy Young MD ***; Youn, Yeo Kyu MD +++; Park, Cheong Soo MD [P]; Kim, Jeong Soo MD,